Allergan Eye Drop Antitrust Suit Revived By 3rd Circ.

The Third Circuit on Wednesday vacated a lower court's dismissal of a pharmacy chain's putative class action against Allergan over eye care products Zymar and Zymaxid, saying the district court was...

Already a subscriber? Click here to view full article